With Taltz, up to 90% of people saw a significant improvement of their psoriasis plaques
4 out of 10 achieved completely clear skin
Embrace the chance
of completely clear skin
With Taltz, up to 90% of people saw a significant improvement of their psoriasis plaques
4 out of 10 achieved completely clear skin
Taltz is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light).
Do not use Taltz if you have had a severe allergic reaction to ixekizumab or any of the other ingredients in Taltz.
Important Safety Information
Do not use Taltz if you have had a severe allergic reaction to ixekizumab or any of the other ingredients in Taltz. See the Medication Guide for a complete list of ingredients in Taltz. If you have a severe allergic reaction, do not take another injection of Taltz.
Taltz is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. Taltz may increase your risk of infections, which can sometimes become serious.
Your healthcare provider (HCP) should check you for tuberculosis (TB) before you begin treatment with Taltz and may treat you for TB if you have a history of TB or have TB
Your HCP should watch you closely for signs and symptoms of TB during and after treatment with Taltz
Before starting Taltz, tell your HCP(s) if you
are being treated for an infection
have an infection that does not go away or that keeps coming back
have or have had TB, or have been in close contact with someone with TB
think you have an infection or have symptoms of an infection, such as
fever, sweats, or chills
muscle aches
cough
shortness of breath
blood in your phlegm (mucus)
weight loss
warm, red, or painful skin or sores on your body
diarrhea or stomach pain
burning when you urinate or urinating more often than usual
have Crohn’s disease or ulcerative colitis
recently received or are scheduled to receive an immunization (vaccine). People who take Taltz should not receive live vaccines. Prior to starting Taltz, consider completion of all age-appropriate immunizations according to current immunization guidelines
are pregnant or plan to become pregnant. It is not known if Taltz can harm your unborn baby
are breastfeeding or plan to breastfeed. It is not known if Taltz passes into your breast milk
After starting Taltz, call your HCP right away if you have any of the symptoms of infection listed above. Do not use Taltz if you have any symptoms of infection, unless you are instructed to by your HCP.
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Taltz may cause serious side effects, including
Serious allergic reactions. Get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
feeling faint
swelling of your face, eyelids, lips, mouth, tongue, or throat
trouble breathing or throat tightness
chest tightness
skin rash
Inflammatory bowel disease (Crohn's disease or ulcerative colitis) can happen during treatment with Taltz, including worsening symptoms. Tell your HCP if you have new or worsening symptoms of inflammatory bowel disease during treatment with Taltz, including stomach pain, diarrhea (with or without blood in stool), or weight loss
The most common side effects of Taltz include: injection site reactions, nausea, fungal infections, and upper respiratory infections. These are not all of the possible side effects of Taltz. Tell your HCP about any side effect that bothers you or that does not go away.
Call your HCP for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit fda.gov/medwatch or call 1-800-FDA-1088.
Store Taltz in the refrigerator, and protect it from light. Do not freeze Taltz or use Taltz if it has been frozen. Do not shake Taltz.
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click “Continue” to leave site or “Return to taltz.com” to close this window and return to taltz.com.
Eligibility Criteria
By using the Taltz Savings Card ("Card"), you attest that you meet the eligibility criteria and will comply with the Terms and Conditions described below:
Offer void where prohibited by law. This offer is invalid for patients without commercial insurance coverage or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DOD, VA, TRICARE/CHAMPUS, or any state patient or pharmaceutical assistance program. If you live in Massachusetts, the Card expires on the earlier of: (i) the expiration date of this Card (December 31, 2018); (ii) the date an AB-rated generic equivalent for Taltz becomes available; or (iii) July 1, 2017, absent a change in Massachusetts state law. Available only in the US and Puerto Rico for residents of the US and Puerto Rico.
By accepting this offer, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you should notify your insurance carrier of your redemption of this Card. This offer is not valid with any other program, discount, incentive, or similar offer involving Taltz. It is prohibited for any person to sell, purchase or trade; or to offer to sell, purchase or trade; or to counterfeit this Card. This offer may be terminated, rescinded, revoked, or amended by Lilly USA, LLC, at any time without notice. This Card is not health insurance. This Card expires on 12/31/2018. Patients must first use their card by 12/31/2016 and are eligible for savings for up to 24 months of therapy.
*Pay no more than $25 monthly and as little as $5 monthly. $5 Monthly offer subject to a maximum annual benefit of $16,000. $25 Monthly offer subject to a monthly and annual cap of usual and customary pharmacy charges. If you meet program eligibility requirements, have commercial insurance, and your insurance provider covers Taltz, you are eligible to pay $5 monthly. If you meet program eligibility requirements, have commercial insurance, and your insurance provider denies coverage for Taltz after 2 requests for coverage attempts, you are eligible to pay $25 monthly. To participate in the $25 monthly program, eligible patients will need to contact Taltz Together to verify eligibility. To continue to participate in the $25 program, patients who qualify for the $25 monthly program are required to have a new benefits investigation and request for coverage completed 3 months post program initiation, 6 months post program initiation, and then every 6 months thereafter, as well as in January of every year, to verify coverage status and potential eligibility for the $5 monthly program. Card activation for both the $5 and $25 monthly programs is good for up to 24 months from patient qualification into the program. Subject to the terms and conditions of the program, patients may be eligible to re-enroll provided they continue to meet program criteria.
†Eligibility Criteria: By using the Taltz Savings Card ("Card"), you attest that you meet the eligibility criteria and will comply with the Terms and Conditions described below:
Offer void where prohibited by law. This offer is invalid for patients without commercial insurance coverage or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DOD, VA, TRICARE/CHAMPUS, or any state patient or pharmaceutical assistance program. If you live in Massachusetts, the Card expires on the earlier of: (i) the expiration date of this Card (December 31, 2018); (ii) the date an AB-rated generic equivalent for Taltz becomes available; or (iii) July 1, 2017, absent a change in Massachusetts state law. Available only in the US and Puerto Rico for residents of the US and Puerto Rico.
By accepting this offer, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you should notify your insurance carrier of your redemption of this Card. This offer is not valid with any other program, discount, incentive, or similar offer involving Taltz. It is prohibited for any person to sell, purchase or trade; or to offer to sell, purchase or trade; or to counterfeit this Card. This offer may be terminated, rescinded, revoked, or amended by Lilly USA, LLC, at any time without notice. This Card is not health insurance. This Card expires on 12/31/2018. Patients must first use their Card by 12/31/2016 and are eligible for savings for up to 24 months of therapy.